Debra Frye

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

21h-index4.3kcitations44works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(28), Breast Cancer Treatment Studies(18), HER2/EGFR in Cancer Research(10), Colorectal Cancer Treatments and Studies(8), Breast Lesions and Carcinomas(5)

Publications44 total

Recommendations for Enhancing Clinical Trials Education: a Review of the Literature
Journal of Cancer Education·2010· 18 cited
Advances in breast cancer treatment: the emerging role of ixabepilone
Expert Review of Anticancer Therapy·2009· 8 cited
Phase I Study of Prolonged-Infusion Gemcitabine Combined with Cyclophosphamide in Patients with Metastatic Carcinoma of the Breast: Tolerability of an Optimal Dose Schedule
Oncology·2009· 2 cited
Current Clinical Issues in Systemic Therapy for Metastatic Breast Cancer
Clinical journal of oncology nursing·2009· 1 cited
New Options for Metastatic Breast Cancer
Clinical journal of oncology nursing·2009· 5 cited
Capecitabine-Based Combination Therapy for Breast Cancer: Implications for Nurses
Oncology nursing forum·2009· 4 cited
Clinical Course of Breast Cancer Patients With Metastases Limited to the Liver Treated With Chemotherapy
The Cancer Journal·2008· 59 cited
Taxane Chemotherapy—Advances in Treatment for Breast Cancer
touchREVIEWS in Oncology & Haematology·2006· 2 citedOpen Access
Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks
Journal of Clinical Oncology·2005· 418 cited
Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer
Journal of Clinical Oncology·2005· 1.2k citedOpen Access
A Phase I and Pharmacokinetic Study of TAS-108 in Postmenopausal Female Patients with Locally Advanced, Locally Recurrent Inoperable, or Progressive Metastatic Breast Cancer
Clinical Cancer Research·2004· 18 citedOpen Access
The Use of Alternate, Non–Cross-Resistant Adjuvant Chemotherapy on the Basis of Pathologic Response to a Neoadjuvant Doxorubicin-Based Regimen in Women With Operable Breast Cancer: Long-Term Results From a Prospective Randomized Trial
Journal of Clinical Oncology·2004· 145 citedOpen Access
First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study
Breast Cancer Research·2003· 53 citedOpen Access
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
PubMed·2002· 162 cited
Phase I study of eniluracil and oral 5‐fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma
Cancer·2002
Phase I study of eniluracil and oral 5‐fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma
Cancer·2002· 2 cited
Multicenter Phase II Study of a 28-Day Regimen of Orally Administered Eniluracil and Fluorouracil in the Treatment of Patients With Anthracycline- and Taxane-Resistant Advanced Breast Cancer
Journal of Clinical Oncology·2002· 16 cited
Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
PubMed·2002· 41 cited
Phase I Study of Vinorelbine and Docetaxel with Granulocyte Colony-Stimulating Factor Support in the Treatment of Metastatic Breast Cancer
Cancer Investigation·2002· 12 cited
Long-Term Results of Combined-Modality Therapy for Locally Advanced Breast Cancer With Ipsilateral Supraclavicular Metastases: The University of Texas M.D. Anderson Cancer Center Experience
Journal of Clinical Oncology·2001· 214 cited
page 1 of 3Next →

Frequent Co-authors

Gabriel N. Hortobágyi(34), Aman U. Buzdar(21), Vicente Valero(15), Richard L. Theriault(14), Daniel J. Booser(13), Frankie A. Holmes(10), Nuhad K. Ibrahim(9), Marsha D. McNeese(9), Giuseppe Fraschini(8), S. Eva Singletary(7), Edgardo Rivera(7), Frederick C. Ames(7), Terry L. Smith(6), Ronald S. Walters(6), Eric A. Strom(6), Lina Asmar(6), Kelly K. Hunt(5), Ayşegül A. Şahin(5), Massimo Cristofanilli(4), Shu‐Wan Kau(4)